Andrey Semechkin insider trades: International Stem Cell (ISCO.OB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrey reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 21, 2019 | ISCO.OB | ↑ Buy | 599,222 | $1.75 | $1.0M | Direct | Jan 22, 2019 (1d) |
| Dec 7, 2017 | ISCO.OB | ↑ Buy | 1,860,810 | $1.75 | $3.3M | Direct | Dec 8, 2017 (1d) |
| May 22, 2017 | ISCO.OB | ↑ Buy | 3,200 | $1.64 | $5K | Direct | May 24, 2017 (2d) |
| Mar 22, 2017 | ISCO.OB | ↑ Buy | 10,000 | $1.67 | $17K | Direct | Mar 22, 2017 (0d) |
| Mar 14, 2017 | ISCO.OB | ↑ Buy | 8,100 | $1.41 | $11K | Direct | Mar 14, 2017 (0d) |
| Dec 8, 2016 | ISCO.OB | ↑ Buy | 285,714 | $1.75 | $500K | Direct | Dec 8, 2016 (0d) |
| Sep 14, 2016 | ISCO.OB | ↑ Buy | 200,000 | $1.75 | $350K | Direct | Sep 15, 2016 (1d) |
| Aug 22, 2016 | ISCO.OB | ↑ Buy | 154,285 | $1.75 | $270K | Direct | Aug 23, 2016 (1d) |
| Jun 29, 2016 | ISCO.OB | ↑ Buy | 215,000 | $1.75 | $376K | Direct | Jun 30, 2016 (1d) |
| Mar 31, 2015 | ISCO.OB | ↑ Buy | 5,894,214 | $0.04 | $264K | Direct | Apr 2, 2015 (2d) |
| Dec 22, 2014 | ISCO.OB | ↑ Buy | 5,894,214 | $0.06 | $340K | Direct | Dec 24, 2014 (2d) |
| Sep 10, 2014 | ISCO.OB | ↑ Buy | 3,888,889 | $0.09 | $350K | Direct | Sep 12, 2014 (2d) |
| Aug 6, 2014 | ISCO.OB | ↑ Buy | 5,000,000 | $0.10 | $500K | Direct | Aug 8, 2014 (2d) |
| Jun 26, 2014 | ISCO.OB | ↑ Buy | 4,800,000 | $0.10 | $480K | Direct | Jun 30, 2014 (4d) |
| May 29, 2014 | ISCO.OB | ↑ Buy | 2,870,000 | $0.15 | $431K | Direct | Jun 2, 2014 (4d) |
| Jul 24, 2013 | ISCO:OB | ↑ Buy | 5,998,999 | $0.15 | $900K | Direct | Jul 26, 2013 (2d) |
| Mar 12, 2013 | ISCO.OB | ↑ Buy | 500,000 | $0.20 | $100K | Direct | Mar 14, 2013 (2d) |
| Jan 22, 2013 | ISCO | ↑ Buy | 10,000,000 | $0.20 | $2.0M | Direct | Jan 24, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Andrey Semechkin's insider trades
Andrey Semechkin is Chief Executive Officer at International Stem Cell (ISCO.OB). Since Jan 22, 2013, Andrey has reported 18 open-market purchases worth $11.2M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), other transactions (13 filings), option exercises (10 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ISCO.OB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.